DocLiv transforms pharmacogenetics and clinical data into patient-specific therapy rankings, helping clinicians choose safer, more effective treatments for each individual patient.

This is not a single recommendation. It is an ordered landscape of options, re-ranked as patient context evolves, built to prevent avoidable harm, reduce ineffective therapy, and make decisions reproducible under genomic data governance.

Docliv delivers precision medicine where it matters most: fast, local, clinically anchored.


Based in Zürich, Docliv develops advanced health technologies such as LEVI, a next-generation gene browser for pharmacogenetics, designed to bring precision medicine into everyday clinical practice.

By combining secure, high-performance software with deep PGx expertise, Docliv advances clinical intelligence, enabling personalized medication strategies and more effective, data-driven care.

DocLiv

Org chart

Teams

Offices